Cobitolimod Phase 3 Program Discontinued for Ulcerative Colitis Treatment
This phase 3 program was advised to discontinue given that cobitolimod was shown to be less likely to meet its primary endpoint.
Source: hcplive.com
Page 8 - Phase 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phase 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phase 3 Today - Breaking & Trending Today
Euclid breaks ground on Kenny Yuko Park, part of Waterfront Improvement Plan
Euclid announced Nov. 10 that Phase 3 of its Waterfront Improvement Plan was officially underway with contractors Great Lakes Crushing starting work on Kenny Yuko Park last week.
Source: news-herald.com
IO Biotech enrolls 380 Patients in phase 3 advanced melanoma trial
IO Biotech, a clinical-stage biopharma company developing therapeutic cancer vaccines, has completed enrollment in its phase 3 trial for IO102-IO103, in combination with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced melanoma.
Source: biopharma-reporter.com
Seladelpar Improves Markers of Cholestasis, Pruritus in Patients with PBC
Phase 3 data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases demonstrated the safety and efficacy of seladelpar in patients with primary biliary cholangitis through 12 months of treatment.
Source: hcplive.com
Resmetirom Significantly Reduces LDL-C, Restore Thyroid Hormones in NASH with Fibrosis
New analyses from the phase 3 MAESTRO-NASH support the oral daily drug's benefit for cardiovascular and hormonal outcomes over 1 year.
Source: hcplive.com